Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

INZY Inozyme Pharma Inc

3,05

0,24 (8,54%)

21 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Inozyme Pharma (NASDAQ:INZY)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Inozyme Pharma Charts.

Inozyme Pharma (NASDAQ:INZY)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Inozyme Pharma Charts.

News Inozyme Pharma Inc

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Montag 9 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Inozyme Pharma to Participate in the Piper Sandler 36th Annual Healthcare Conference
Mittwoch 27 November 2024 (4 Wochen vor) • GlobeNewswire Inc.

Inozyme Pharma to Present at Upcoming Investor Conferences
Montag 11 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Freitag 8 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 5 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 5 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Inozyme Pharma Reports Third Quarter 2024 Financial Results and Provides Business Highlights
Dienstag 5 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 24 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Inozyme Pharma Announces Positive Interim Data from Phase 1 SEAPORT 1 Trial of INZ-701
Donnerstag 24 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Inozyme Pharma Announces Presentation of Interim Data from Phase 1 SEAPORT 1 Trial at the Upcoming American Society of Nephrology (ASN) Kidney Week 2024
Donnerstag 17 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Inozyme Pharma Announces Appointment of Biopharmaceutical Commercial Leader Erik Harris to its Board of Directors
Montag 7 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 4 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Inozyme Pharma Inc News-Artikel

JP Morgan Chase

Health Care Select Sector

Euro vs Sterling

Deutsche Telekom (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen